NRC Health Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax
NRC Health (NRC) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax of -$198.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax · last filed 2016-11-04
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2016-09-30 was -$198.00K.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2016-06-30 was $5.00K, a 98.25% decline year-over-year.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2016-03-31 was $874.00K.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2015-09-30 was -$1.03M.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2014 was -$1.07M.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2013 was -$822.00K, a 478.80% decline from fiscal 2012.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2012 was $217.00K.
- NRC Health other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2011 was -$201.00K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 12 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2016-09-30 | -$198.00K 10-Q · filed 2016-11-04 | -$193.00K derived: sum of 2 quarters · filed 2016-11-04 | $680.00K 10-Q · filed 2016-11-04 | ||
| 2016-06-30 | $5.00K 10-Q · filed 2016-08-05 | $878.00K 10-Q · filed 2016-08-05 | |||
| 2016-03-31 | $874.00K 10-Q · filed 2016-05-06 | ||||
| 2015-09-30 | -$1.03M 10-Q · filed 2016-11-04 | -$743.00K derived: sum of 2 quarters · filed 2016-11-04 | -$1.80M 10-Q · filed 2016-11-04 | -$2.34M derived: sum of 4 quarters · filed 2016-11-04 | |
| 2015-06-30 | $285.00K 10-Q · filed 2016-08-05 | -$769.00K 10-Q · filed 2016-08-05 | -$1.31M derived: sum of 3 quarters · filed 2016-08-05 | -$1.90M derived: sum of 4 quarters · filed 2016-08-05 | |
| 2015-03-31 | -$1.05M 10-Q · filed 2016-05-06 | -$1.60M derived: sum of 2 quarters · filed 2016-05-06 | -$2.19M derived: sum of 3 quarters · filed 2016-05-06 | -$1.72M derived: sum of 4 quarters · filed 2016-05-06 | |
| 2014-12-31 | -$542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$1.13M derived: sum of 2 quarters · filed 2016-03-04 | -$670.00K derived: sum of 3 quarters · filed 2016-03-04 | -$1.07M 10-K · filed 2016-03-04 | |
| 2014-09-30 | -$590.00K 10-Q · filed 2015-11-05 | -$128.00K derived: sum of 2 quarters · filed 2015-11-05 | -$533.00K 10-Q · filed 2015-11-05 | -$977.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $462.00K 10-Q · filed 2015-08-06 | $57.00K 10-Q · filed 2015-08-06 | -$387.00K derived: sum of 3 quarters · filed 2016-03-04 | -$146.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | -$405.00K 10-Q · filed 2015-05-08 | -$849.00K derived: sum of 2 quarters · filed 2016-03-04 | -$608.00K derived: sum of 3 quarters · filed 2016-03-04 | ||
| 2013-12-31 | -$444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$203.00K derived: sum of 2 quarters · filed 2016-03-04 | -$822.00K 10-K · filed 2016-03-04 | ||
| 2013-09-30 | $241.00K 10-Q · filed 2013-11-07 | -$378.00K 10-Q · filed 2013-11-07 | |||
| 2012-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $276.00K derived: sum of 2 quarters · filed 2015-03-04 | $217.00K 10-K · filed 2015-03-04 | ||
| 2012-09-30 | $419.00K 10-Q · filed 2013-11-07 | $360.00K 10-Q · filed 2013-11-07 | |||
| 2011-12-31 | -$201.00K 10-K · filed 2014-03-04 | ||||
| 2010-12-31 | -$201.00K 10-K · filed 2014-03-04 | $339.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |